Governance
The PIONeeR Project RHU is led by a consortium bridging together Aix-Marseille Université (AMU), Inserm, CNRS, the "Assistance Publique Hôpitaux de Marseille" (AP-HM), Gustave Roussy, Centre Léon-Bérard de Lyon (CLB), ImCheck Therapeutics, Innate Pharma, Veracyte and AstraZeneca.
Discover the members of the Independent Scientific Advisory Board (SAB)
Dr. Bernard A. FOX, Président
Pr. Solange PETERS
Pr. Ming TSAO
Pr. Martin RECK
Dr. Daniel TAN
Focus
KEY FIGURES: 2555 days, 3 countries, more than 100 scientists, 8 research labs, 17 hospitals, 225,510,000€ including 8,502,000€ of NRA funding
RHU COORDINATOR : Aix-Marseille Université
CLINICAL TRIAL SPONSOR : Assistance Publique Hôpitaux de Marseille
PROJECT INITIATOR : Marseille Immunopole
DIRECTION : Professeur Fabrice BARLESI (Université Paris-Saclay, Institut Gustave Roussy)
They are involved in the PIONeeR project
